FDA Approves GSK Asthma Drug for Younger Children
Posted March 23, 2006 3:26 a.m. EST
RESEARCH TRIANGLE PARK, N.C. — The U.S. Food and Drug Administration has granted its approval for the winder use of the
asthma drug known as Flovent HFA.
Flovent can now be prescribed for children ages 4 to 11, GSK said Thursday.
Some 3.6 million children ages 5-11 have asthma, according to federal health statistics cited by GSK.
Flovent was approved for use for patients ages 12 and older in 2004.